Efficacy and Safety of <scp>CKDB</scp>‐<scp>501A</scp> in Treating Moderate‐To‐Severe Glabellar Lines: A Randomized, Double‐Blind, Active‐Controlled, Multi‐Center Phase <scp>III</scp> Trial
Authors
Yi Na Yoon (ORCID: https://orcid.org/0000-0001-8050-1750)
Won‐Serk Kim (ORCID: https://orcid.org/0000-0001-8795-0866)
Sun Young Choi (ORCID: https://orcid.org/0000-0003-0248-7708)
Jin Seop Kim (ORCID: https://orcid.org/0000-0002-7854-1726)
Beom Joon Kim (ORCID: https://orcid.org/0000-0002-2719-3012)
Botulinum Toxin and Related Neurological Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Efficacy and Safety of CKDB‐501A in Treating Moderate‐To‐Severe Glabellar Lines: A Randomized, Double‐Blind, Active‐Controlled, Multi‐Center Phase III Trial
Yi Na Yoon, Won‐Serk Kim, Sun Young Choi, Jin Seop Kim et al.
Journal
Journal of Cosmetic Dermatology
Topics
Botulinum Toxin and Related Neurological Disorders
article
Efficacy and Safety of CKDB‐501A in Treating Moderate‐To‐Severe Glabellar Lines: A Randomized, Double‐Blind, Active‐Controlled, Multi‐Center Phase III Trial
Yi Na Yoon, Won‐Serk Kim, Sun Young Choi, Jin Seop Kim, Beom Joon Kim, Yang Won Lee
article en
Abstract
No abstract available for this paper.
Publication Tag
Journal of Cosmetic DermatologyVol. 24(7)
Institutions
Konkuk University (KR), Kangbuk Samsung Hospital (KR), Chung-Ang University Hospital (KR), Sungkyunkwan University (KR)
Sustainable Development Goals
Good health and well-being
OpenAlex Percentile
Openalex Percentile: Top 76%
Topics
Botulinum Toxin and Related Neurological Disorders